Guidant
This article was originally published in The Gray Sheet
Executive Summary
Shipments of the Discovery II single-sensor pacemaker will begin in early April following FDA approval via PMA supplement, annouced March 16. The device's "expanded diagnostic capability will complement our very successful blended sensor product, the Pulsar Max pacemaker," Guidant notes